Quantification Of The Wear-Off Effect Towards The End Of The Intravenous Immunoglobulin Infusion Interval: Pooled Data Analysis by Lawo, John-Philip, Mr, Hubsch, Alphonse, Dr, Rojavin, Mikhail, Dr

Get full text

Flexible Dosing For Hizentra®: Pharmacokinetic Simulations Of Various Subcutaneous Dosing Regimens and Compliance In Patients With Primary Immunodeficiency by Rojavin, Mikhail, Dr, Sidhu, Jagdev S., Dr, Bexon, Martin, Dr, Edelman, Jonathan M., Dr

Get full text

Pharmacokinetic Modeling Predicts Different IgG Exposures Using Different IVIG-Scig Dose Conversion Factors In Patients With Primary Immune Deficiency by Sidhu, Jagdev S., Dr, Rojavin, Mikhail, Dr, Berger, Melvin, Dr, Bexton, Martin, Dr, Edelman, Jonathan M., Dr

Get full text

Efficacy and Tolerability Of Privigen® In Clinical Practice by Dorsey, Morna J., Dr, Ho, Viet, Mabudian, Mohsen I., Dr, Soler-Palacín, Pere, Domínguez-Pinilla, Nerea, Hellmers, Robert W., Dr, Rishi, Radha Gandhi, Dr, Rishi, Rahul, Wong, Duane W., Dr, Rojavin, Mikhail, Dr, Hubsch, Alphonse, Dr, Berger, Melvin, Dr

Get full text

Safety, Tolerability, and Efficacy Of Hizentra® In Japanese Patients With Primary Immunodeficiency Over 48 Weeks by Imai, Kohsuke, Prof, Kanegane, Hirokazu, Prof, Yamada, Masafumi, Prof, Takada, Hidetoshi, Prof, Ariga, Tadashi, Prof, Kobayashi, Midori, Ms, Rojavin, Mikhail, Dr, Bexon, Martin, Dr, Nonoyama, Shigeaki, Prof, Hara, Toshiro, Prof, Miyawaki, Toshio, Prof

Get full text

Health-Related Quality Of Life Of Japanese Patients With Primary Immunodeficiency Diseases Receiving IgPro20, a 20% Liquid Subcutaneous Immunoglobulin (Hizentra®) by Kanegane, Hirokazu, Prof, Imai, Kohsuke, Prof, Yamada, Masafumi, Prof, Takada, Hidetoshi, Prof, Ariga, Tadashi, Prof, Igarashi, Ataru, Prof, Tsutani, Kiichiro, Prof, Bexon, Martin, Dr, Rojavin, Mikhail, Dr, Kobayashi, Midori, Ms, Lawo, John-Philip, Dr, Zbrozek, Art, Mr, Nonoyama, Shigeaki, Prof, Hara, Toshiro, Prof, Miyawaki, Toshio, Prof

Get full text